Terns Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver…

Biotechnology
US, Foster City [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Terns Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Terns Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Terns Pharmaceuticals, Inc..

End of TERN's Analysis
CIK: 1831363 CUSIP: 880881107 ISIN: US8808811074 LEI: - UEI: -
Secondary Listings
TERN has no secondary listings inside our databases.